S. 27: Preserve Access to Affordable Generics Act
112th Congress, 2011–2012
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
Sponsor:
Sen. Herbert “Herb” Kohl [D-WI]
Status:
Reported by Committee
-----
The next vote on this bill will occur in the Senate.
For more information, Google:
Preserve Access to Affordable Generics Act
Full Text of S. 27: Preserve Access to Affordable Generics Act
http://www.govtrack.us/congress/bills/112/s27/text
Doc